Journal
FUTURE ONCOLOGY
Volume 10, Issue 8, Pages 1501-1513Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/FON.14.21
Keywords
blood test; data analysis methods; early detection; high-risk population; lung cancer; multiple biomarker panels; screening
Categories
Funding
- CONACYT Mexico [FOSISS-2008-1-87628]
- CONACYT
Ask authors/readers for more resources
Considerable efforts have been undertaken to produce an effective screening method to reduce lung cancer mortality. Imaging tools such as low-dose computed tomography has shown an increase in the detection of early disease and a reduction in the rate of death. This screening modality has, however, several limitations, such as overdiagnosis and a high rate of false positives. Therefore, new screening methods, such as the use of circulating protein biomarkers, have emerged as an option that could complement imaging studies. In this review, current imaging techniques applied to lung cancer screening protocols are presented, as well as up-to-date status of circulating protein biomarker panels that may improve lung cancer diagnosis. Additionally, diverse statistical and artificial intelligence tools applied to the design and optimization of these panels are discussed along with the presentation of two commercially available blood tests recently developed to help detect lung cancer early.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available